Visit https://www.peervoice.com/VSB860 to view the entire programme with slides. After completing “Melanie J. Davies, CBE, FRCP, FMedSci / Linong Ji, MD - Managing the Cost of Type 2 Diabetes: The Impact of Effective Use of Established Therapies”, participants will be able to: Describe the importance of optimal cost-effective approaches to the pharmacologic management of type 2 diabetes mellitus (T2DM); Evaluate the role of established medications for T2DM for avoiding potential cardiorenal complications in patients with T2DM; and Propose practical approaches to address cost and clinical effectiveness for patients with T2DM.